Clinical Trials
10 trialsNCT03157167 2025-03-05
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Navidea Biopharmaceuticals
Phase 1 Completed
NCT03677960 2019-07-24
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Terminated
NCT03202992 2019-02-07
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Completed
NCT00002136 2005-06-24
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002137 2005-06-24
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002138 2005-06-24
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002153 2005-06-24
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002262 2005-06-24
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002327 2005-06-24
The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002342 2005-06-24
A Study of Tecogalan Sodium
NIH AIDS Clinical Trials Information Service
Phase 1 Completed